Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib

BACKGROUND: Antibiotic treatment (ABT) affects the outcome of cancer patients treated with immune checkpoint inhibitors (ICIs) and chemotherapy, possibly by altering the gut microbiome. We investigated the impact of ABT on overall survival (OS) and progression-free survival (PFS) in patients with ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomej, Katharina, Balcar, Lorenz, Scheiner, Bernhard, Semmler, Georg, Meischl, Tobias, Mandorfer, Mattias, Reiberger, Thomas, Müller, Christian, Trauner, Michael, Pinter, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643200/
https://www.ncbi.nlm.nih.gov/pubmed/34877268
http://dx.doi.org/10.2147/JHC.S317957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643200/
https://www.ncbi.nlm.nih.gov/pubmed/34877268
http://dx.doi.org/10.2147/JHC.S317957

Ejemplares similares